Pathogen Detection And Characterization With Revelo™

Revelo™ RNA-Seq High Sensitivity offers a powerful solution for transcriptome analysis from degraded or low-input human samples, including FFPE tissues and nasal swabs. With a streamlined 6.5-hour workflow, this technology enables robust library preparation and sensitive detection of rare and low-abundance transcripts—even from as little as 250 pg of RNA. Proprietary innovations like DimerFree®, SPIABoost™, and NuQuant® enhance library quality, suppress background noise, and simplify quantification. The platform demonstrates superior performance in detecting viral sequences, including SARS-CoV-2, across a wide range of viral loads and RNA integrity levels. Ideal for applications in cancer research, viral surveillance, and whole transcriptome profiling, Revelo RNA-Seq High Sensitivity empowers researchers to extract meaningful data from even the most challenging samples.

Explore the full application note to see comparative performance data and detailed specifications.